Literature DB >> 15346056

Inferior vena cava filters prevent pulmonary emboli in patients with metastatic pathologic fractures of the lower extremity.

Joseph Benevenia1, Christopher Bibbo, Dipak V Patel, Mark G Grossman, Philip F Bahramipour, Peter J Pappas.   

Abstract

The records of 47 consecutive patients with metastatic pathologic fractures of the lower extremity were analyzed with respect to thromboembolic complications. All patients were unable to receive pharmacologic deep venous thrombosis prophylaxis, and were stratified into two groups, based on use of an inferior vena cava filter. Group I (n = 24) consisted of patients who had an inferior vena cava filter plus mechanical deep venous thrombosis prophylaxis (compression stockings and sequential compression boots); Group II (n = 23) consisted of a group of patients receiving only mechanical deep venous thrombosis prophylaxis. All patients had routine lower extremity venous duplex imaging preoperatively, postoperatively, and before hospital discharge. At final followup, patients were examined for deep venous thrombosis and reviewed for thromboembolic events. At a mean followup of 11.5 months, Group I had two detectable deep venous thromboses and no pulmonary emboli; Group II had one detectable deep venous thrombosis and five pulmonary embolisms. In Group II, 40% (two of five) of pulmonary embolisms were fatal, yielding an 8.7% (two of 23) group mortality rate. Overall, the entire group had an approximately 17% deep venous thrombosis rate. Only 6.4% (three of 47) of deep venous thromboses were detectable by standard duplex imaging. The majority of deep venous thromboses (five of eight, 62.5%) were nondetectable by duplex imaging. Overall, a 4.3% (two of 47) death rate was attributable to pulmonary embolism. In contrast, an 8.6% (four of 47) mortality rate occurred in Group II alone. All pulmonary embolisms occurred in patients who did not receive an inferior vena cava filter. The majority of venous thromboses (62.5%) were not detectable on duplex scanning, therefore were thought to arise from the pelvic venous system. Complications related to inferior vena cava filter insertion were minimal. For patients with metastatic pathologic fractures of the lower extremities who are unable to receive pharmacologic deep venous thrombosis prophylaxis, the use of inferior vena cava filters, in conjunction with standard mechanical deep venous thrombosis prophylaxis, is a procedure that has a low risk and is useful adjunct to prevent fatal pulmonary embolisms.

Entities:  

Mesh:

Year:  2004        PMID: 15346056     DOI: 10.1097/01.blo.0000131641.89360.f2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.

Authors:  Olivier Q Groot; Paul T Ogink; Nuno Rei Paulino Pereira; Marco L Ferrone; Mitchell B Harris; Santiago A Lozano-Calderon; Andrew J Schoenfeld; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

2.  High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.

Authors:  Olivier Q Groot; Paul T Ogink; Stein J Janssen; Nuno Rui Paulino Pereira; Santiago Lozano-Calderon; Kevin Raskin; Francis Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

Review 3.  Using inferior vena cava filters to prevent pulmonary embolism.

Authors:  John Chung; Richard J T Owen
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

4.  IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery.

Authors:  Benjamin Tuy; Chinmoy Bhate; Kathleen Beebe; Francis Patterson; Joseph Benevenia
Journal:  Clin Orthop Relat Res       Date:  2008-11-07       Impact factor: 4.176

5.  Incidence and risk factors for pulmonary embolism after primary musculoskeletal tumor surgery.

Authors:  Koichi Ogura; Hideo Yasunaga; Hiromasa Horiguchi; Kazuhiko Ohe; Hirotaka Kawano
Journal:  Clin Orthop Relat Res       Date:  2013-05-21       Impact factor: 4.176

6.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10

7.  Comparison of Venous Thromboembolism after Total Artificial Joint Replacement between Musculoskeletal Tumors and Osteoarthritis of the Knee by a Single Surgeon.

Authors:  Dong Fu; Yiqiong Zhao; Jiakang Shen; Zhengdong Cai; Yingqi Hua
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

8.  Perioperative d-dimer levels in patients with musculoskeletal tumors.

Authors:  Takeshi Morii; Kazuo Mochizuki; Masazumi Kotera; Naoaki Imakiire; Takahiro Moriwaki; Kazuhiko Satomi
Journal:  Open Orthop J       Date:  2008-08-26

9.  Is DVT prophylaxis necessary after oncology lower limb surgery? A pilot study.

Authors:  Vivek Ajit Singh; Lim Ming Yong; Anushya Vijayananthan
Journal:  Springerplus       Date:  2016-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.